• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Medeor Therapeutics Announces Interim Data from Pivotal Trial Showing Cell Therapy Technology Could Eliminate Life-Long Need for Immunosuppressant Drugs Following Kidney Transplant

    BUSINESSWIRE

    Medeor’s cell therapy boosts immune tolerance in registrational trial

    ENDPTS

    Cell therapy allows kidney recipients to cut immunosuppressants

    FIERCE BIOTECH

    Medeor Therapeutics to Provide Interim Results of Ph3 Mercury Study of MDR-101

    BUSINESSWIRE

    Medeor Therapeutics to Provide Interim Results of Ph3 Mercury Study of MDR-101

    BUSINESSWIRE

    Medeor Completes Enrollment and Transplantation for Pivotal Trial of MDR-101

    BUSINESSWIRE

    Medeor Completes Enrollment & Transplantation for Pivotal Trial of MDR-101

    BIOSPACE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.